arrow
N

Nikita Kotlov

bostongene corporation
H指数:18
被引数:3,567

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical utility of real-time comprehensive molecular testing in large B-cell lymphoma

实时全面分子检测在大型B细胞淋巴瘤中的临床应用

2026-07-290
OA
Transcriptomic Profiling and Tumor Microenvironment Classification Reveal Unique and Dynamic Immune Biology in HIV-Associated Kaposi Sarcoma

转录组分析和肿瘤微环境分类揭示了HIV相关卡波西肉瘤独特而动态的免疫生物学

CELLS
IF5.2
2025-01-170
OAAI
Viral Transcript and Tumor Immune Microenvironment-Based Transcriptomic Profiling of HPV-Associated Head and Neck Squamous Cell Carcinoma Identifies Subtypes Associated with Prognosis

基于病毒转录和肿瘤免疫微环境的HPV相关头颈部鳞状细胞癌转录组图谱鉴定与预后相关的亚型

2024-12-240
OAAI
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
2024-11-150
OA
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

Duvelisib联合romidepsin治疗复发/难治性T细胞淋巴瘤: 1b/2a期试验

2024-06-171
PRE
Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data

Procrustes是一种机器学习方法,可从临床RNA测序数据中消除跨平台批次效应

2024-03-303
OAAI
Genomic distinctions of HIV- and EBV-associated DLBCL in a diverse African cohort
2024-03-220
PRE
An analysis of 13 independently performed assays to measure homologous recombination deficiency using 90 freshly extracted high grade serous ovarian tumors: findings from the friends of cancer research hrd harmonization project
2024-03-040
PRE
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis

破译未知原发癌的起源和治疗靶点: 说明整合全外显子组和转录组测序分析能力的病例报告

2024-01-220
OAAI
IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism

IL-8通过潜在的细胞外囊泡miR-146a介导的机制与HPV阳性HNSCC对nivolumab的新辅助治疗无反应相关

2023-07-044
OAAI
B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma

肿瘤微环境中的b细胞浸润与切除的肺腺癌生存率提高有关

2023-07-011
OA